Recent Finacing
Recent Raise
Reata Pharmaceuticals develops oral anti-inflammatory therapeutics, advancing bardoxolone methyl for advanced CKD in Type 2 diabetes, running pivotal clinical trials, building US commercial organization, and partnering in Asia.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors